The facility is an extension of the company's USFDA-approved plant that is already supplying to the US, Europe, Japan and ...
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA ...
Inhibition of group IVA cytosolic phospholipase A2 (cPLA2α) is a potential approach for cancer treatment. Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound ...
Mexico President Claudia Sheinbaum said Tuesday that President Donald Trump’s executive order moving toward designating drug ...
Introduction to Generative AI Generative AI refers to algorithms that can create new content, including text, images, music, ...
The US Food and Drug Administration (FDA)’s recently issued final rule establishing application, labeling, and postmarketing reporting ...
The Food and Drug Administration issued marketing granted orders to 20 Zyn nicotine pouch products. The announcement on ...
On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device ...
Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback